Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
IMCR Immunocore
- 30.220
- +0.220+0.73%
Trading Jan 22 12:51 ET
1.51BMarket Cap-31.81P/E (TTM)
30.520High29.970Low134.04KVolume30.000Open30.000Pre Close4.03MTurnover0.36%Turnover RatioLossP/E (Static)50.03MShares76.98052wk High4.00P/B1.12BFloat Cap27.69052wk Low--Dividend TTM36.98MShs Float76.980Historical High--Div YieldTTM1.83%Amplitude18.430Historical Low30.057Avg Price1Lot Size
About Immunocore Company
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolIMCR
Company NameImmunocore
Listing DateFeb 5, 2021
Issue Price26.00
Founded2021
CEODr. Bahija Jallal, PhD
MarketNASDAQ
Employees497
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address92 Park Drive,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RY
Phone44-1235-438600
Websitehttp://immunocore.com
Company Executives
- Name
- Position
- Salary
- Dr. Bahija Jallal, PhD
- Chief Executive Officer and Director
- 11.68M
- John Goll
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Travis Coy
- Executive Vice President, Chief Financial Officer and Head of Corporate Development
- --
- Tina St. Leger
- Chief Human Resources Officer
- 1.04M
- Professor Sir John Bell
- Chairman of the Board
- 416.99K
- Ranjeev Krishana
- Director
- --
- Robert J. Perez
- Independent Director
- --
- Kristine Peterson
- Independent Director
- 389.49K
- Siddharth Kaul
- Independent Director
- 386.99K
- Roy Steven Herbst, M.D.
- Independent Director
- 386.99K
- Professor Sir Peter Ratcliffe
- Independent Director
- 384.49K
- Dr. David Berman, M.D.
- Head of Research and Development
- 4.40M
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
Trump's return, earnings ahead: Can Tesla continue to climb?
🎙️Discussion: 1. With Trump's return, can Tesla's stock price continue to rise in 2025? 2. Tesla is set to release its earnings report aft
BullnBearTrading
Jan 3 16:30
🚗 Tesla Q4 Dip: Time to Buy , or Is the Risk Too High? 📉